Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAd3-EBO-Z Ebola vaccine study in healthy adults in West and Central Africa
PACTR201504001092179Not yet recruiting
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 5
01
Overview
Single-arm trial of cAd3-EBOV in Ebola virus disease (EVD), sponsored by GSK. Planned start May 2015; status: not yet recruiting.
02
Drugs
cAd3-EBOV
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR201504001092179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201504001092179.